Clinical Trials in Philadelphia

Showing 2701-2720 of 17,926 trials

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

NCT05480449

This study will determine the safety and efficacy of moving to a second-generation manufacturing process using the CliniMACS Prodigy platform to manufacture huCART19 cells for patients with B cell Acute Lymphoblastic Leukemia (B-ALL).

B Cell Acute Lymphoblastic Leukemia (B-ALL)B Lineage Lymphoblastic Lymphoma

Stephan Grupp MD PhD89 participantsStarted Sep 2022

Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

Prevention of Colorectal Cancer Through Multiomics Blood Testing

NCT04369053

The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Colon CancerRectal CancerColon Neoplasm+8 more

Freenome Holdings Inc.48,995 participantsStarted May 2020

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +145 more locations

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Find Trials by Condition in Philadelphia

Study of Pregnancy And Neonatal Health (SPAN)

Vancomycin Reduction Practices (VRP) in the NICU

Transpyloric Feeding for Prevention of Micro-aspiration

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

SpineTRACK Registry - Spinal Outcomes Registry

Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening

Let's Know!2: Language-focused Intervention for Children at Risk of Comprehension Difficulties

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

A Study to Evaluate the Safety, Pharmacokinetics, and Occurrence of Anti-Drug Antibodies Following Annual Doses of CD388

IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors